Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04918667
PHASE1

Effect of Gamma-cyclodextrin on the Bioavailability of Berberine

Sponsor: EuroPharma, Inc.

View on ClinicalTrials.gov

Summary

In this study, we will evaluate the relative bioavailability of Berberine (BB) from capsules containing Indian Barberry (Berberis aristate DC.) Bark and Root Extract in the blood plasma of healthy subjects after oral administration of: A. Capsules containing Berberine and GCD (BBA Berberine MetX™ Ultra Absorption, 250 mg) B. Capsules containing Berberine (BB, Berberine MetX™, 500 mg) - (reference product).

Official title: A Phase I, Randomized, Crossover, Double-blind, Pharmacokinetic Study of Berberine Released From Cyclodextrin in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2024-09

Completion Date

2026-12

Last Updated

2023-09-14

Healthy Volunteers

Yes

Conditions

Interventions

COMBINATION_PRODUCT

Berberine incorporated in gamma cyclodextrin

Experimental modified product. One capsule contains 250 mg of Berberine from Indian Barberry (Berberis aristate DC.) Bark and Root Extract incorporated in gamma-cyclodextrin

DIETARY_SUPPLEMENT

Berberine

Active comparator. One capsule contains 500 mg of Berberine from Indian Barberry (Berberis aristate DC.) Bark and Root Extract

Locations (4)

CARDIOMED Family Health Center, LLC of the Ministry of Health of the Republic of Armenia

Yerevan, Armenia

Institute of Fine Organic Chemistry of the National Academy of Science

Yerevan, Armenia

Scientific Center of Drug and Medical Technologies Expertise

Yerevan, Armenia

Phytomed AB

Våxtorp, HL, Sweden